The ocean (opicapone effect on motor fluctuations and associated pain) study in Parkinson's disease: Design and rationale of a randomized double-blind placebo-controlled trial

2021 ◽  
Vol 429 ◽  
pp. 119424
Author(s):  
K. Ray Chaudhuri ◽  
Per Odin ◽  
Joaquim Ferreira ◽  
Angelo Antonini ◽  
Olivier Rascol ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Controlled Trial ◽  
Motor Fluctuations ◽  
Double Blind ◽  
Double Blind Placebo

Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double-blind placebo-controlled trial

2007 ◽  
Vol 22 (2) ◽  
pp. 179-186 ◽  
Author(s):  
Christopher G. Goetz ◽  
Philippe Damier ◽  
Christine Hicking ◽  
Eugene Laska ◽  
Thomas Müller ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

2011 ◽  
Vol 27 (1) ◽  
pp. 106-112 ◽  
Author(s):  
Fabrizio Stocchi ◽  
Rupam Borgohain ◽  
Marco Onofrj ◽  
Anthony H.V. Schapira ◽  
Mohit Bhatt ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Early Parkinson’S Disease

scholarly journals Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

The Lancet ◽  
2017 ◽  
Vol 390 (10103) ◽  
pp. 1664-1675 ◽  
Author(s):  
Dilan Athauda ◽  
Kate Maclagan ◽  
Simon S Skene ◽  
Martha Bajwa-Joseph ◽  
Dawn Letchford ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document